Bendamustine salvage for relapsed - refractory multiple myeloma: a retrospective analysis of outcomes in heavily pretreated patients

被引：0
|
作者：
Singh, Aakanksha [1 ]
Agrawal, Narendra [1 ]
Haldar, Rohan [1 ]
Bhurani, Dinesh [1 ]
Raychoudhari, Jyoti Shankar [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, New Delhi, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-314
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [21] Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma
    Salomon-Perzynski, Aleksander
    Walter-Croneck, Adam
    Usnarska-Zubkiewicz, Lidia
    Dytfeld, Dominik
    Zielinska, Patrycja
    Wojciechowska, Malgorzata
    Holojda, Jadwiga
    Robak, Pawel
    Pasternak, Anna
    Knopinska-Posluszny, Wanda
    Hawrylecka, Dorota
    Wojtowicz, Marcin
    Szeremet, Agnieszka
    Osowiecki, Michal
    Mordak-Domagala, Monika
    Zaucha, Jan Maciej
    Giannopoulos, Krzysztof
    Warzocha, Krzysztof
    Jamroziak, Krzysztof
    ADVANCES IN MEDICAL SCIENCES, 2019, 64 (02): : 349 - 355
  • [22] Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Tiedemann, Rodger
    Kukreti, Vishal
    LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 555 - 560
  • [23] Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study
    Russo, Antonio
    Ricci, Francesca
    Magagnoli, Massimo
    Rodari, Marcello
    Morello, Lucia
    Mazza, Rita
    Chiti, Arturo
    Castagna, Luca
    Santoro, Armando
    Carlo-Stella, Carmelo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S234 - S234
  • [24] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Dharshan Sivaraj
    Michael M Green
    Yubin Kang
    Gwynn D Long
    David A Rizzieri
    Zhiguo Li
    Anderson H Garrett
    Jackie L McIntyre
    Nelson J Chao
    Cristina Gasparetto
    Blood Cancer Journal, 8
  • [25] Bendamustine therapy for advanced relapsed/refractory multiple myeloma
    Shkury, Eden
    Geva, Mika
    Avigdor, Abraham
    Nevo, Lee
    Magen, Hila
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S189 - S189
  • [26] BENDAMUSTINE : A NEW OPTION FOR RELAPSED/ REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Madonna, E.
    Marano, L.
    Pugliese, N.
    Avilia, S.
    Cerciello, G.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2013, 98 : 612 - 612
  • [27] Combination chemotherapy with bortezomib, bendamustine and prednisone for patients with refractory/relapsed multiple myeloma:: An unicentric retrospective trial
    Poenisch, W.
    Bourgeois, M.
    Wang, S. Y.
    Heyn, S.
    Jaekel, N.
    Braunert, L.
    Pfannes, R.
    Nehring, C.
    Nehring, C.
    Becker, C.
    Becker, C.
    Al Ali, H.
    Hensel, G.
    Niederwieser, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 432 - 432
  • [28] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Kang, Yubin
    Long, Gwynn D.
    Rizzieri, David A.
    Li, Zhiguo
    Garrett, Anderson H.
    McIntyre, Jackie L.
    Chao, Nelson J.
    Gasparetto, Cristina
    BLOOD CANCER JOURNAL, 2018, 8
  • [29] The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma
    Oriol, Albert
    Abril, Laura
    Torrent, Anna
    Ibarra, Gladys
    Ribera, Josep-Maria
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [30] Real-World Safety and Efficacy of Talquetamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma
    Shaikh, Hira
    Lochner, Jonathan
    Friend, Reed
    Snyder, Jordan
    Davis, James
    Patrus, Gina
    Dileo, Rachel
    Ahmed, Nausheen
    Mewawalla, Prerna
    Poonsombudlert, Kittika
    Struble, Emily
    Wolcott, Allyson
    Green, Kimberly
    Sparrow, Samantha
    Mushtaq, Muhammad Umair
    Paul, Barry
    Abdallah, Al-Ola
    Strouse, Christopher
    Hashmi, Hamza
    Atrash, Shebli
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S87 - S88
12345